Effects of Immunoadsorption on the nt-BNP and nt-ANP Plasma Levels of Patients Suffering From Dilated Cardiomyopathy

: Immunoadsorption (IA) represents an additional therapeutic approach in patients with severe heart failure due to dilated cardiomyopathy (DCM). nt‐BNP and nt‐ANP plasma levels are prognostic markers in patients with heart failure. The effect of IA on nt‐BNP and nt‐ANP plasma levels is unknown. In...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Therapeutic apheresis and dialysis 2006-02, Vol.10 (1), p.42-48
Hauptverfasser:	Staudt, Alexander, Staudt, Yvonne, Hummel, Astrid, Empen, Klaus, Dörr, Marcus, Trimpert, Christiane, Birkenmeier, Katrin, Kühl, Uwe, Noutsias, Michel, Russ, Dirk, Felix, Stephan B
Format:	Artikel
Sprache:	eng
Schlagworte:	ANP Atrial Natriuretic Factor - blood Biomarkers - blood BNP Cardiomyopathy, Dilated - blood Cardiomyopathy, Dilated - physiopathology Cardiomyopathy, Dilated - therapy Dilated cardiomyopathy Female Heart Failure - therapy Humans Immunoadsorption Immunosorbent Techniques Male Middle Aged Natriuretic Peptide, Brain - blood Peptide Fragments - blood Prognosis Ventricular Function, Left
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	: Immunoadsorption (IA) represents an additional therapeutic approach in patients with severe heart failure due to dilated cardiomyopathy (DCM). nt‐BNP and nt‐ANP plasma levels are prognostic markers in patients with heart failure. The effect of IA on nt‐BNP and nt‐ANP plasma levels is unknown. In this case control study, 30 patients suffering from severe heart failure (LVEF
ISSN:	1744-9979 1744-9987
DOI:	10.1111/j.1744-9987.2006.00343.x